| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Nov 2025 | 5 Nov 2025 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve Unaudited financial result for the half year ended on 30th September 2025 along with the Auditors Limited Review Report. Board meeting of the company adjourned to tomorrow i.e. November 12, 2025 due to unavoidable circumstances. With reference to the above cited subject, this is to inform it was intimated that the meeting of Board of Directors of the Company is scheduled to be held on Tuesday, November 11, 2025, inter-alia to consider and approve Un-audited Financial Results of the Company for the Second quarter and Half year ended on September 30, 2025. This is to intimate that in the Board Meeting held today, the Chairman with the consent of all the directors present at the meeting hereby decided to adjourn the Meeting of Board of Directors due to unavoidable circumstances and decided that the Meeting of Board of Directors will continue to be held on Wednesday, November 12, 2025 inter-alia to consider and approve Un-audited Financial Results of the Company for the Second quarter and Half year ended on September 30, 2025 and any other item with the permission of Chairman. (As per BSE Announcement dated on: 11.11.2025) The Board meeting of the company further adjourned on Thursday November 13, 2025 due to unavoidable circumstances. (As Per BSE Announcement Dated on 12.11.2025) This is to intimate that in the Board Meeting held today, the Chairman with the consent of all the directors present at the meeting hereby decided to further adjourn the Meeting of Board of Directors due to unavoidable circumstances and decided that the Meeting of Board of Directors will continue to be held on Friday, November 14, 2025 inter-alia to consider and approve Un-audited Financial Results of the Company for the Second quarter and Half year ended on September 30, 2025 and any other item with the permission of Chairman (As Per BSE Announcement Dated on 13.11.2025) Outcome Of The Meeting Of The Board Of Directors Held On Friday, November 14, 2025. (As Per BSE Announcement Dated on: 19/11/2025) | ||
| Board Meeting | 13 Aug 2025 | 8 Aug 2025 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Unaudited financial result for the first quarter ended on 30th June 2025 along with the Auditors Limited Review Report Un-Audited Financial Results (UFR) for the first quarter ended June 30, 2025, along with the Statutory Auditors Limited Review Report. (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 29 May 2025 | 23 May 2025 |
| Audited Results - Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on 31st March, 2025 along with the Auditors Report and Certificate for unmodified opinion Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015; Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, the Board of Directors of the at their meeting held on today i.e., Thursday, May 29, 2025 at the Registered Office of the Company inter-alia has, considered and approved Standalone Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2025, along with Statement of Profit & Loss, Statement of Assets & Liabilities and the Statement of Cash Flow, for the financial year ended March 31, 2025, in accordance with the provisions of Regulation 33 of the SEBI Listing Regulations, along with the Auditors Reports thereon. (As Per BSE Announcement Dated on: 12/06/2025) | ||
| Board Meeting | 23 May 2025 | 17 May 2025 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on 31st March 2025 along with the Auditors Report and Certificate for unmodified opinion Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015; | ||
| Board Meeting | 21 Mar 2025 | 21 Mar 2025 |
| Outcome of the meeting of Independent directors of the company held today to consider agendas as attached. | ||
| Board Meeting | 14 Feb 2025 | 11 Feb 2025 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve Unaudited financial result for the third quarter ended on 31st December 2024 along with the Auditors Limited Review Report. Outcome of the meeting of the Board of Directors held on Friday, February 14, 2025 (As Per BSE Announcement Dated on: 26/02/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.